It's also interesting that those with the delta32 homozygous mutation have reduced life expectancy and increased risk of death from influenza and equine encephalitis, both viral conditions.

So again, leronlimab hits the CCR receptor just right, like a magic key, to unlock your own body's immune system to function optimally. It is almost a magic key to unlocking a self contained in vivo CART therapy for cancer and other conditions. Could it make CART obsolete before it even gets of the ground?

Just IMO